Related Experiment Videos
Plama-thromboglobulin concentrations in diabetes mellitus
Lancet (London, England)
|February 4, 1978
Summary
Elevated levels of platelet protein thromboglobulin were found in diabetic patients, particularly those with tissue damage. This blood abnormality may indicate future complications even before clinical signs appear.
Area of Science:
- Biochemistry
- Hematology
- Endocrinology
Background:
- Diabetes mellitus is a complex metabolic disorder associated with microvascular and macrovascular complications.
- Platelet activation and aggregation play a significant role in the pathogenesis of diabetic complications.
- Thromboglobulin is a protein released from activated platelets, serving as a marker of platelet activation.
Purpose of the Study:
- To investigate plasma concentrations of thromboglobulin in diabetic patients.
- To determine the correlation between thromboglobulin levels and the presence of clinical tissue damage in diabetes.
- To explore the potential of thromboglobulin as an early indicator of diabetic complications.
Main Methods:
- Plasma samples were collected from 72 diabetic patients.
- Plasma concentrations of thromboglobulin were measured using established biochemical assays.
- Patients were assessed for clinical evidence of tissue damage.
Main Results:
- Abnormally high plasma concentrations of thromboglobulin were observed in the studied diabetic patient group.
- The highest thromboglobulin levels were detected in patients exhibiting clinical signs of tissue damage.
- Elevated thromboglobulin levels were also present in diabetic patients without overt complications, suggesting a potential preclinical marker.
Conclusions:
- Elevated plasma thromboglobulin is a common finding in diabetic patients.
- Thromboglobulin levels correlate with the severity of tissue damage in diabetes.
- Increased thromboglobulin may serve as an early biomarker for predicting the development of diabetic complications, preceding clinical manifestation.